Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
01
Overview
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA is a synthetic small molecule dipeptide derivative containing a boronic acid moiety. It is classified as an experimental compound and has not been approved for clinical use. The structure features protected amino acids, including gamma-D-glutamic acid, L–lysine with a carbobenzoxy (CBZ or Z-) group, and D-boroalanine. The presence of the boronic acid group suggests potential activity as a protease inhibitor or enzyme modulator, but no specific mechanism of action or therapeutic indication has been established in the literature[2][3][7]. There are no known clinical trials or approved uses for this compound.
- Other names
- Boc-gamma-D-glu-L-lys(cbz)-D-boroala(2S)-4-(((1S)-5-(((benzyloxy)carbonyl)amino)-1-(((1S)-1-(dihydroxyboranyl)ethyl)carbamoyl)pentyl)carbamoyl)-2-(((tert-butoxy)carbonyl)amino)butanoic acidN-(tert-butoxycarbonyl)-L-gamma-glutamyl-N~6~-[(benzyloxy)carbonyl]-N-[(1S)-1-(dihydroxyboranyl)ethyl]-L-lysinamide
02
Targets
PBP (Penicillin-binding protein family)
Beyond the preview
Go deeper on BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA.